Stock Taper 
| DATE | TYPE | RATIO |
|---|---|---|
| 2010-06-18 | Reverse | 1:3 |
Pro-Dex, Inc. designs and manufactures powered surgical instruments and rotary air motors for medical and industrial markets, offering solutions primarily for orthopedic, thoracic, and craniomaxillofacial applications since 1978.
A battery-powered surgical driver designed for CMF, small bone, and spine procedures, offering precision, reliability, and an ergonomic, lightweight design for complete surgeon control.
Following the announcement of record Q3 2025 financial results, which included a 22% revenue increase and a 45% growth in gross profit, Pro-Dex's stock paradoxically crashed by 32%. This dramatic disconnect between the company's strong performance and the severe negative market reaction put the company firmly in the spotlight, generating significant discussion among investors and analysts regarding the stock's volatility and valuation.
Pro-Dex's most significant strategic shift in 2025 was the successful launch and production ramp-up of a next-generation orthopedic handpiece for its largest customer. This new product line became the primary engine of growth, leading to a significant surge in net sales and a favorable product mix that boosted gross margins substantially.
Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.
Overall rating: A-
| PEER | PRICE | |
|---|---|---|
 GLSI | $14.60 | COMPARE |
 LUCD | $0.63 | COMPARE |
 APYX | $2.38 | COMPARE |
 CGTX | $0.92 | COMPARE |
 SERA | $2.12 | COMPARE |
 MBOT | $1.06 | COMPARE |
 RPID | $0.85 | COMPARE |
 IXHL | $3.19 | COMPARE |
